Ohio Public Employees Retirement System (OPERS)’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
Other funds holding ABUS
TSC
WCM
RCMNY
FCM
Ohio Public Employees Retirement System (OPERS)'s ABUS Position: Q4 2022 in Review
Ohio Public Employees Retirement System (OPERS) sold out of Arbutus Biopharma (ABUS) in Q4 2022, closing a stake of 39,000 shares — an estimated $74K sold.
Ohio Public Employees Retirement System (OPERS) first reported a position in ABUS in Q1 2015 and held it in 2 quarters. The position peaked at $98K in Q1 2015. 114 funds tracked by Wall St. Rank hold ABUS as of Q4 2022.
- Ohio Public Employees Retirement System (OPERS) reported no remaining Arbutus Biopharma position as of Q4 2022 after selling out during the quarter.
- Ohio Public Employees Retirement System (OPERS) sold 39,000 Arbutus Biopharma shares in Q4 2022, an estimated $74K.
- Ohio Public Employees Retirement System (OPERS) first reported a position in Arbutus Biopharma in Q1 2015 and held it in 2 quarters.
- Ohio Public Employees Retirement System (OPERS)'s Arbutus Biopharma position peaked at $98K in Q1 2015.
- 114 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q4 2022.
Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q4 2022, filed 15 Feb 2023.